Clinical Trials Logo

Stage IIA Prostate Cancer clinical trials

View clinical trials related to Stage IIA Prostate Cancer.

Filter by:

NCT ID: NCT02179762 Withdrawn - Clinical trials for Recurrent Prostate Cancer

Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer

EASE
Start date: August 9, 2014
Phase: N/A
Study type: Interventional

This randomized pilot clinical trial compares vigorous or moderate exercise in enhancing active surveillance in patients with prostate cancer that has not spread to nearby lymph nodes or to other parts of the body. Active surveillance involves watching the patient's condition but not giving any treatment unless test results show that the patient's condition is getting worse. Exercise may improve fitness, quality of life, brain health, and blood biomarkers in patients with prostate cancer on active surveillance. It is not yet known whether vigorous or moderate exercise works better in enhancing active surveillance in patients with localized prostate cancer.

NCT ID: NCT02176902 Active, not recruiting - Clinical trials for Adenocarcinoma of the Prostate

Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer

Start date: November 1, 2014
Phase: N/A
Study type: Interventional

This randomized phase II trial will evaluate if a low omega-6, high omega-3 fat diet combined with fish oil has the potential to delay disease progression in patients with prostate cancer undergoing active surveillance.

NCT ID: NCT02163317 Completed - Clinical trials for Adenocarcinoma of the Prostate

Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer

Start date: February 16, 2016
Phase: N/A
Study type: Interventional

This pilot clinical trial studies magnetic resonance (MRI)-guided focal stereotactic radiosurgery (SRS) in treating patients with low- or intermediate-risk localized prostate cancer. Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue.

NCT ID: NCT02144649 Completed - Clinical trials for Stage IV Prostate Cancer

Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery

Start date: June 2015
Phase: N/A
Study type: Interventional

This randomized pilot clinical trial compares tangerine and red tomato juice in treating patients with prostate cancer undergoing surgery. A diet high in lycopene, a substance found in tomatoes, may help prevent normal cells from transforming into cancer cells in patients with prostate cancer.

NCT ID: NCT02119858 Completed - Clinical trials for Stage IIB Prostate Cancer

Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing Surgery

Start date: July 25, 2014
Phase: Phase 1
Study type: Interventional

This clinical trial studies diffuse optical imaging with indocyanine green solution in imaging pelvic lymph nodes in patients with stage II prostate cancer undergoing surgery. Indocyanine green solution is a special dye that can help doctors see the lymph nodes and blood vessels during surgery when visualized under diffuse optical imaging. Indocyanine green solution may improve the ability to detect lymph nodes and may lead to improved accuracy of lymph node removal.

NCT ID: NCT02079155 Withdrawn - Clinical trials for Stage I Prostate Cancer

Robotic Athermal Nerve-Sparing Radical Prostatectomy

Start date: June 2012
Phase: N/A
Study type: Interventional

This randomized clinical trial compares a recently developed technique, called robotic laparoendoscopic single-site radical prostatectomy (R-LESS RP), to the current standard of robotic technique for prostate cancer, robot-assisted laparoscopic prostatectomy (RALP) in treating patients with newly diagnosed, locally confined prostate cancer. Both procedures are types of robotic radical prostatectomy, or the robot-assisted removal of the prostate though a small incision in the belly. In the standard approach, 4-5 small (1-2 cm) incisions are made in the lower abdomen to allow the insertion of robotic instruments. In the R-LESS technique, all instruments are inserted through a single incision. R-LESS RP is less invasive than RALP and may leave a smaller scar and cause less pain.

NCT ID: NCT01992016 Completed - Bone Metastases Clinical Trials

A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine

Start date: April 7, 2014
Phase: N/A
Study type: Interventional

This pilot clinical trial studies fludeoxyglucose F18 (FDG)-positron emission tomography (PET) in imaging patients with prostate cancer treated with ranolazine. Diagnostic procedures, such as FDG-PET, may help find prostate cancer and find out how far the disease has spread. Giving ranolazine may enhance FDG-PET imaging by increasing the amount of glucose available for uptake by the scan.

NCT ID: NCT01928485 Terminated - Clinical trials for Stage I Prostate Cancer

Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer

Start date: August 30, 2013
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies how well green tea extract works in treating patients with low-risk prostate cancer. Green tea extract contains ingredients that may prevent or slow the growth of certain cancers.

NCT ID: NCT01923506 Active, not recruiting - Clinical trials for Recurrent Prostate Cancer

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery

Start date: November 25, 2013
Phase: Phase 1
Study type: Interventional

This phase I trial studies the side effects and best dose of stereotactic body radiation therapy in treating patients with prostate cancer after undergoing surgery. Stereotactic body radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue.

NCT ID: NCT01912820 Completed - Clinical trials for Adenocarcinoma of the Prostate

Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery

Start date: January 1, 2014
Phase: Phase 1
Study type: Interventional

This randomized pilot phase I trial will evaluate if quercetin enhances the uptake of green tea polyphenols in the prostate tissue of men taking green tea extract and undergoing radical prostatectomy. Side effects of green tea extract and quercetin in combination with green tea extract will also be evaluated. In preclinical studies, green tea polyphenols have anticancer and cancer preventative effects in a number of malignancies. Likewise, in preclinical studies quercetin was found to enhance the anticancer effects of green tea. This trial is designed to translate these findings forward in a short-term human intervention trial.